• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $ETHZ

    ETHZilla Corporation

    Subscribe to $ETHZ
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year: 2017

    Exchange: NASDAQ

    Recent Analyst Ratings for ETHZilla Corporation

    DatePrice TargetRatingAnalyst
    See more ratings

    ETHZilla Corporation Press Releases

    Fastest customizable press release news feed in the world

    View All

    ETHZilla Announces ETH Accumulation and Leadership Updates

    Company has accumulated 102,246 ETH at an average acquisition price of $3,948.72, valued at approximately $443 million McAndrew Rudisill appointed as Chief Executive Officer, will continue to serve as Chairman Provides update on previously announced stock repurchase program PALM BEACH, Fla., Sept. 8, 2025 /PRNewswire/ -- ETHZilla Corporation (NASDAQ:ETHZ), (the "Company" or "ETHZilla"), today announced it now has total holdings of 102,246 Ether ("ETH") at an average acquisition price of $3,948.72, which is now valued at approximately $443 million. In addition to the ETH, ETHZilla holds approximately $213 million in USD cash equivalents.

    9/8/25 8:15:00 AM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ETHZilla Plans to Deploy $100 Million in ETH to EtherFi for Restaking Initiatives

    Partnership marks ETHZilla's first engagement with DeFi protocols Company has accumulated 102,246 ETH at an average acquisition price of $3,948.72, valued at approximately $456 million PALM BEACH, Fla., Sept. 2, 2025 /PRNewswire/ -- ETHZilla Corporation (NASDAQ:ETHZ), (the "Company" or "ETHZilla"), today announced its plans to deploy into the decentralized finance (DeFi) ecosystem approximately $100 million of  Ether ("ETH") to EtherFi, a liquid restaking protocol, pursuant to which the Company expects to generate higher yields on its treasury holdings. "Our partnership with E

    9/2/25 8:00:00 AM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ETHZilla announces authorization of $250 million stock repurchase program

    Company has accumulated 102,237 ETH at an average acquisition price of $3,948.72, which is now valued at approximately $489 million Announces implementation of proprietary Electric Asset Protocol to generate higher yields PALM BEACH, Fla., Aug. 25, 2025 /PRNewswire/ -- ETHZilla Corporation (NASDAQ:ETHZ), (the "Company" or "ETHZilla"), today announced that its Board of Directors has authorized a stock repurchase program of up to $250 million of the Company's outstanding shares of common stock, effective immediately. Additionally, the Company announced it now has total holdings of 102,237 Ether ("ETH") at an average acquisition price of $3,948.72, which is now valued at approximately $489 mill

    8/25/25 8:00:00 AM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ETHZilla Corporation SEC Filings

    View All

    ETHZilla Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - ETHZilla Corp (0001690080) (Filer)

    9/8/25 9:29:54 AM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by ETHZilla Corporation

    DEF 14A - ETHZilla Corp (0001690080) (Filer)

    9/5/25 5:12:18 PM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ETHZilla Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - ETHZilla Corp (0001690080) (Filer)

    9/5/25 4:20:58 PM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ETHZilla Corporation filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - ETHZilla Corp (0001690080) (Filer)

    9/2/25 8:00:27 AM ET
    $ETHZ
    Biotechnology: Pharmaceutical Preparations
    Health Care